Complications, symptoms, quality of life and pregnancy in cholestatic liver disease.
Kais ZakhariaAnilga TabibianKeith D LindorJames H TabibianPublished in: Liver international : official journal of the International Association for the Study of the Liver (2017)
Cholestatic liver diseases (CLDs) encompass a variety of disorders of bile formation and/or flow which generally result in progressive hepatobiliary injury and ultimately end-stage liver disease. Many patients with CLD are diagnosed between the ages of 20-50 years, a particularly productive period of life professionally, biologically and in other respects; it is not surprising, thus, that CLD is often associated with impaired health-related quality of life (HRQOL) and uncertainty regarding implications for and outcomes of pregnancy. Primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) are the most prominent CLDs, both having considerable morbidity and mortality and representing major indications for liver transplantation. These disorders, as a consequence of their complications (eg ascites, hepatic osteodystrophy), associated conditions (eg inflammatory bowel disease) and symptoms (eg pruritus and fatigue), can significantly impair an array of domains of HRQOL. Here we review these impactful clinical aspects of PSC and PBC as well as the topics of fertility and pregnancy.
Keyphrases
- preterm birth
- pregnancy outcomes
- liver injury
- sleep quality
- risk factors
- multiple sclerosis
- liver fibrosis
- ulcerative colitis
- drug induced
- pregnant women
- high resolution
- type diabetes
- mass spectrometry
- physical activity
- cell free
- metabolic syndrome
- high throughput
- atopic dermatitis
- adipose tissue
- single cell
- young adults
- insulin resistance